Zinc in PDB 5a5z: Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
Enzymatic activity of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
All present enzymatic activity of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria:
3.5.2.6;
Protein crystallography data
The structure of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria, PDB code: 5a5z
was solved by
F.M.Klingler,
T.A.Wichelhaus,
D.Frank,
J.Cuesta-Bernal,
J.El-Delik,
H.F.Mueller,
H.Sjuts,
S.Goettig,
A.Koenigs,
D.Pogoryelov,
E.Proschak,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.66 /
2.60
|
Space group
|
P 41 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
108.047,
108.047,
92.571,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.8 /
25.2
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
(pdb code 5a5z). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria, PDB code: 5a5z:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5a5z
Go back to
Zinc Binding Sites List in 5a5z
Zinc binding site 1 out
of 4 in the Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn302
b:46.3
occ:1.00
|
ND1
|
A:HIS122
|
2.1
|
42.9
|
1.0
|
NE2
|
A:HIS120
|
2.1
|
40.2
|
1.0
|
NE2
|
A:HIS189
|
2.5
|
49.5
|
1.0
|
CD2
|
A:HIS189
|
3.0
|
61.2
|
1.0
|
CE1
|
A:HIS120
|
3.0
|
40.9
|
1.0
|
CG
|
A:HIS122
|
3.1
|
41.9
|
1.0
|
CD2
|
A:HIS120
|
3.1
|
38.4
|
1.0
|
CE1
|
A:HIS122
|
3.1
|
40.9
|
1.0
|
ZN
|
A:ZN303
|
3.1
|
0.6
|
1.0
|
CB
|
A:HIS122
|
3.3
|
40.6
|
1.0
|
CE1
|
A:HIS189
|
3.7
|
54.6
|
1.0
|
SG
|
A:CYS208
|
3.9
|
51.4
|
1.0
|
OD1
|
A:ASP124
|
4.1
|
47.6
|
1.0
|
ND1
|
A:HIS120
|
4.1
|
38.6
|
1.0
|
NE2
|
A:HIS122
|
4.2
|
41.9
|
1.0
|
CG
|
A:HIS120
|
4.2
|
36.6
|
1.0
|
CD2
|
A:HIS122
|
4.2
|
39.9
|
1.0
|
C04
|
A:WJZ304
|
4.2
|
63.7
|
0.5
|
S01
|
A:WJZ304
|
4.2
|
0.0
|
0.5
|
CG
|
A:HIS189
|
4.3
|
51.8
|
1.0
|
CB
|
A:CYS208
|
4.3
|
44.1
|
1.0
|
OD2
|
A:ASP124
|
4.3
|
52.1
|
1.0
|
C05
|
A:WJZ304
|
4.5
|
56.8
|
0.5
|
CG2
|
A:THR190
|
4.6
|
40.4
|
1.0
|
ND1
|
A:HIS189
|
4.6
|
50.5
|
1.0
|
CG
|
A:ASP124
|
4.6
|
47.0
|
1.0
|
O02
|
A:WJZ304
|
4.8
|
52.6
|
0.5
|
CA
|
A:HIS122
|
4.8
|
38.5
|
1.0
|
O01
|
A:WJZ304
|
4.9
|
54.1
|
0.5
|
|
Zinc binding site 2 out
of 4 in 5a5z
Go back to
Zinc Binding Sites List in 5a5z
Zinc binding site 2 out
of 4 in the Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn303
b:0.6
occ:1.00
|
S01
|
A:WJZ304
|
2.4
|
0.0
|
0.5
|
OD2
|
A:ASP124
|
2.4
|
52.1
|
1.0
|
N01
|
A:WJZ304
|
2.8
|
65.9
|
0.5
|
C03
|
A:WJZ304
|
2.9
|
70.9
|
0.5
|
NE2
|
A:HIS250
|
2.9
|
58.2
|
1.0
|
C04
|
A:WJZ304
|
3.0
|
63.7
|
0.5
|
SG
|
A:CYS208
|
3.1
|
51.4
|
1.0
|
C02
|
A:WJZ304
|
3.1
|
74.1
|
0.5
|
ZN
|
A:ZN302
|
3.1
|
46.3
|
1.0
|
CG
|
A:ASP124
|
3.3
|
47.0
|
1.0
|
CE1
|
A:HIS250
|
3.5
|
55.2
|
1.0
|
O03
|
A:WJZ304
|
3.5
|
69.1
|
0.5
|
OD1
|
A:ASP124
|
3.6
|
47.6
|
1.0
|
O02
|
A:WJZ304
|
3.7
|
52.6
|
0.5
|
C05
|
A:WJZ304
|
3.7
|
56.8
|
0.5
|
CD2
|
A:HIS250
|
4.1
|
56.5
|
1.0
|
NE2
|
A:HIS189
|
4.1
|
49.5
|
1.0
|
CB
|
A:CYS208
|
4.3
|
44.1
|
1.0
|
CB
|
A:ASP124
|
4.4
|
41.4
|
1.0
|
C01
|
A:WJZ304
|
4.5
|
71.9
|
0.5
|
NE2
|
A:HIS120
|
4.5
|
40.2
|
1.0
|
CE1
|
A:HIS189
|
4.6
|
54.6
|
1.0
|
ND1
|
A:HIS122
|
4.6
|
42.9
|
1.0
|
ND1
|
A:HIS250
|
4.7
|
54.9
|
1.0
|
CE1
|
A:HIS120
|
4.8
|
40.9
|
1.0
|
O01
|
A:WJZ304
|
4.8
|
54.1
|
0.5
|
CB
|
A:HIS122
|
5.0
|
40.6
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5a5z
Go back to
Zinc Binding Sites List in 5a5z
Zinc binding site 3 out
of 4 in the Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn302
b:36.4
occ:1.00
|
ND1
|
C:HIS122
|
2.1
|
49.1
|
1.0
|
NE2
|
C:HIS189
|
2.1
|
44.0
|
1.0
|
NE2
|
C:HIS120
|
2.2
|
42.6
|
1.0
|
ZN
|
C:ZN303
|
2.9
|
82.8
|
1.0
|
CD2
|
C:HIS189
|
3.0
|
43.2
|
1.0
|
CD2
|
C:HIS120
|
3.1
|
39.8
|
1.0
|
CE1
|
C:HIS122
|
3.1
|
41.9
|
1.0
|
CG
|
C:HIS122
|
3.1
|
42.9
|
1.0
|
CE1
|
C:HIS120
|
3.2
|
44.3
|
1.0
|
CE1
|
C:HIS189
|
3.2
|
44.5
|
1.0
|
CB
|
C:HIS122
|
3.4
|
42.2
|
1.0
|
SG
|
C:CYS208
|
3.6
|
51.9
|
1.0
|
CB
|
C:CYS208
|
4.0
|
45.6
|
1.0
|
OD1
|
C:ASP124
|
4.0
|
45.2
|
1.0
|
S01
|
C:WJZ304
|
4.1
|
0.1
|
0.5
|
CG
|
C:HIS189
|
4.2
|
42.8
|
1.0
|
NE2
|
C:HIS122
|
4.2
|
37.9
|
1.0
|
CG
|
C:HIS120
|
4.2
|
39.3
|
1.0
|
ND1
|
C:HIS189
|
4.2
|
42.8
|
1.0
|
OD2
|
C:ASP124
|
4.2
|
52.1
|
1.0
|
ND1
|
C:HIS120
|
4.3
|
41.9
|
1.0
|
CD2
|
C:HIS122
|
4.3
|
41.5
|
1.0
|
CG2
|
C:THR190
|
4.5
|
41.1
|
1.0
|
CG
|
C:ASP124
|
4.6
|
47.7
|
1.0
|
O01
|
C:WJZ304
|
4.6
|
53.3
|
0.5
|
CA
|
C:HIS122
|
4.9
|
40.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5a5z
Go back to
Zinc Binding Sites List in 5a5z
Zinc binding site 4 out
of 4 in the Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta- Lactamases: Strategy to Combat Multidrug-Resistant Bacteria within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn303
b:82.8
occ:1.00
|
OD2
|
C:ASP124
|
2.5
|
52.1
|
1.0
|
S01
|
C:WJZ304
|
2.6
|
0.1
|
0.5
|
SG
|
C:CYS208
|
2.9
|
51.9
|
1.0
|
ZN
|
C:ZN302
|
2.9
|
36.4
|
1.0
|
NE2
|
C:HIS250
|
3.0
|
56.6
|
1.0
|
N01
|
C:WJZ304
|
3.1
|
63.4
|
0.5
|
O01
|
C:WJZ304
|
3.1
|
53.3
|
0.5
|
CG
|
C:ASP124
|
3.3
|
47.7
|
1.0
|
OD1
|
C:ASP124
|
3.6
|
45.2
|
1.0
|
CE1
|
C:HIS250
|
3.7
|
51.1
|
1.0
|
C02
|
C:WJZ304
|
3.8
|
69.0
|
0.5
|
C03
|
C:WJZ304
|
3.8
|
64.4
|
0.5
|
C05
|
C:WJZ304
|
3.9
|
55.3
|
0.5
|
NE2
|
C:HIS189
|
3.9
|
44.0
|
1.0
|
C04
|
C:WJZ304
|
4.0
|
57.9
|
0.5
|
CB
|
C:CYS208
|
4.1
|
45.6
|
1.0
|
CE1
|
C:HIS189
|
4.1
|
44.5
|
1.0
|
CD2
|
C:HIS250
|
4.2
|
52.4
|
1.0
|
NE2
|
C:HIS120
|
4.4
|
42.6
|
1.0
|
ND1
|
C:HIS122
|
4.5
|
49.1
|
1.0
|
CB
|
C:ASP124
|
4.6
|
40.5
|
1.0
|
O03
|
C:WJZ304
|
4.9
|
63.0
|
0.5
|
CE1
|
C:HIS120
|
4.9
|
44.3
|
1.0
|
ND1
|
C:HIS250
|
4.9
|
51.3
|
1.0
|
O02
|
C:WJZ304
|
5.0
|
54.0
|
0.5
|
CD2
|
C:HIS189
|
5.0
|
43.2
|
1.0
|
CB
|
C:HIS122
|
5.0
|
42.2
|
1.0
|
|
Reference:
F.M.Klingler,
T.A.Wichelhaus,
D.Frank,
J.Cuesta-Bernal,
J.El-Delik,
H.F.Muller,
H.Sjuts,
S.Gottig,
A.Koenigs,
K.M.Pos,
D.Pogoryelov,
E.Proschak.
Approved Drugs Containing Thiols As Inhibitors of Metallo-Beta-Lactamases: Strategy to Combat Multidrug-Resistant Bacteria. J. Med. Chem. V. 58 3626 2015.
ISSN: ISSN 1520-4804
PubMed: 25815530
DOI: 10.1021/JM501844D
Page generated: Sun Oct 27 12:39:32 2024
|